Page 5 – Redenlab

Speech and language in children with Klinefelter syndrome

Posted on February 19, 2019
by Redenlab
Language, Publications

Background Speech and language deficits are frequent in males with Klinefelter syndrome (KS), yet the research base is slim and specific strengths and deficits in communication have not been well characterised. Nor have studies examined…

Posted on March 12, 2019
by Redenlab
Blog

Prof Angela Morgan of Murdoch Childrens Research Institute with Prof Barbara Dodd, partnering with Redenlab receive funding from the Victorian Medical Research Acceleration Fund for ‘Developing a digital speech treatment tool to treat speech disorders’

Posted on March 12, 2019
by Redenlab
Blog, Publications

Redenlab partnered with investigators in Australia and Germany to conduct dysarthria treatment trial in ataxia published in Journal of Neurology Abstract: We aimed to provide proof-of-principle evidence that intensive home-based speech treatment can improve dysarthria…

Posted on March 12, 2019
by Redenlab
Blog, Publications

Abstract Objective The study aim was to determine if use of illicit amphetamines or ecstasy is associated with abnormal excitability of the corticomotoneuronal pathway and manipulation of novel objects with the hand. Methods Three groups…

Posted on April 12, 2019
by Redenlab
Blog, Publications

Children born preterm are at risk of impairments in oromotor control, with implications for early feeding and speech development. In this study, we aimed to identify (a) neuroanatomical markers of persistent oromotor deficits using diffusion-weighted…

Posted on April 12, 2019
by Redenlab
Blog, Publications

Infants with a history of early, prolonged hospitalisation (e.g. due to preterm birth) are widely known to experience adverse neurodevelopmental outcomes. Researchers have suggested that some of these neurodevelopmental outcomes might be attributed to the…

Posted on April 12, 2019
by Redenlab
Blog, Publications

Background: Tremor is present in almost half of multiple sclerosis (MS) patients. The lack of understanding of its pathophysiology is hampering progress in development of treatments. Objectives: To clarify the structural and functional brain changes…

Posted on May 2, 2019
by Redenlab
Blog, Publications

Purpose The purpose of this study was to expand the genetic architecture of neurodevelopmental disorders, and to characterize the clinical features of a novel cohort of affected individuals with variants in ZNF142, a C2H2domain-containing transcription factor.…

Posted on May 7, 2019
by Redenlab
Speech

BackgroundSubmucous cleft palate (SMCP) has a heterogeneous presentation and is often identified late or misdiagnosed. Diagnosis is prompted by speech, resonance or feeding symptoms associated with velopharyngeal insufficiency. However, the broader impacts of SMCP on…

Posted on May 8, 2019
by Redenlab
Blog, Publications

Autosomal-recessive cerebellar ataxias (ARCAs) comprise a heterogeneous group of rare degenerative and metabolic genetic diseases that share the hallmark of progressive damage of the cerebellum and its associated tracts. This Review focuses on recent translational…

Speech and language in children with Klinefelter syndrome

Redenlab partner with Murdoch Childrens Research Institute in pediatric digital speech testing project

Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS

Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control

Corticobulbar tract injury, oromotor impairment and language plasticity in adolescents born preterm

Music therapy for neurodevelopment in hospitalised infants

Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis

Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia

Exploring the speech and language of individuals with non‐syndromic submucous cleft palate: a preliminary report

Autosomal recessive cerebellar ataxias: Paving the way toward targeted molecular therapies – by our long-time collaborator Prof Matthis Synofzik (Tuebingen)

Categories